Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Abeona Therapeutics Inc. (ABEO) had Return on Equity of 44.71% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$5.82M |
|
$71.18M |
|
$1.53M |
|
$4.29M |
|
$95.27M |
|
$-89.45M |
|
$160.73M |
|
$71.28M |
|
$71.28M |
|
$71.18M |
|
$71.18M |
|
$71.18M |
|
$71.18M |
|
$-89.45M |
|
$-85.89M |
|
52.95M |
|
66.14M |
|
$1.34 |
|
$1.01 |
|
| Balance Sheet Financials | |
$204.91M |
|
$9.92M |
|
$14.66M |
|
$219.57M |
|
$29.57M |
|
$7.81M |
|
$30.78M |
|
$60.35M |
|
$159.22M |
|
$159.22M |
|
$159.22M |
|
55.04M |
|
| Cash Flow Statement Financials | |
$-76.33M |
|
$105.03M |
|
$26.04M |
|
$23.70M |
|
$78.44M |
|
$54.74M |
|
$10.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.93 |
|
-- |
|
-- |
|
0.05 |
|
0.13 |
|
73.68% |
|
-1536.91% |
|
-1536.91% |
|
-1475.69% |
|
1224.79% |
|
1223.08% |
|
$-84.30M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.28 |
|
0.87 |
|
421.13 |
|
|
Return on Equity |
44.71% |
44.71% |
|
32.42% |
|
42.62% |
|
$2.89 |
|
$-1.27 |
|
$-1.15 |
|